Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 427.00
Bid: 420.00
Ask: 434.00
Change: 3.00 (0.71%)
Spread: 14.00 (3.333%)
Open: 427.00
High: 427.00
Low: 427.00
Prev. Close: 424.00
SAG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

19 May 2016 07:00

RNS Number : 6525Y
Science Group PLC
19 May 2016
 

 

19 May 2016

 

 

Science Group plc

(the "Company")

 

 

Trading update

 

Science Group plc provides the following update ahead of the Company's Annual General Meeting this morning.

 

Overall the Group performance in the first 4 months of the year is in line with the Board's expectations. At 30 April 2016, the Group had gross cash of £18.4 million and net funds of £10.9 million.

 

As a science-based services business with limited forward visibility, the Group has seen the benefits from the increase in diversification of client end-markets derived from the acquisition programme. In Q1, the Oil & Gas market continued to be challenging and the Medical business continued to suffer from the lack of new projects to replace those completed in 2015. However, following a change in Group management structure and US sales leadership, a number of significant projects have been won in the Medical sector in recent months which should improve performance in this business for the remainder of the year. The Group's other three business areas have performed satisfactorily, with Leatherhead (food & beverage) outperforming the Board's expectations in terms of profit contribution. As a result, in aggregate, Group revenue and adjusted operating profit to date are in line with the Board's expectations.

 

With a significant proportion of the Group's revenue denominated in US Dollars or Euros, there is an inherent sensitivity within the financial results related to foreign currency exchange fluctuations. While this effect impacts most international companies, IFRS accounting results in Science Group being particularly susceptible due to the majority of the Group's non-Sterling denominated invoices being raised directly from the UK. In brief, IFRS accounting requires that in this operating model, the balance sheet (debtor and WIP) of the relevant operating UK subsidiary is revalued each month with any positive or negative movement being recognised in the Group P&L; in the case where the non-Sterling revenues are invoiced from an in-country subsidiary, such variances would be recognised directly in reserves, although in pre-tax cash terms there is no material difference. This accounting anomaly results in significant additional FX volatility in the reported IFRS Group P&L statement but has the cash benefit of recording profits in the UK (where the work is undertaken) with its lower corporation tax rate. The recent volatility in Sterling-US Dollar exchange rates has brought this issue into sharp focus but the Board considers that the cash benefit to the Group outweighs the non-cash IFRS P&L reporting volatility.

 

The works at Great Burgh, Epsom have now received planning consent and, despite the delays in this process, relocation of the Leatherhead and OTM businesses remains on track to be completed over the summer. Approximately 80 employees are now based at Epsom and feedback from client events held there in recent weeks has been excellent. Following the purchase of the Great Burgh freehold property, the Board has now commenced negotiations regarding the possibility of increasing the Group's banking facilities, such debt to be secured on the Group's substantial freehold property assets which had a carrying value of £20.9 million as at 31 December 2015.

 

- Ends -

 

For further information:

Science Group plc

Martyn Ratcliffe, Chairman

Tel: +44 (0) 1223 875 200

Rebecca Hemsted, Finance Director

 

Numis Securities Limited

Nominated Adviser: Simon Willis / Paul Gillam

Tel: +44 (0) 20 7260 1000

Corporate Broking: Michael Burke

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUWVVRNRAVAAR
Date   Source Headline
2nd May 20247:00 amRNSIssue of share options & PDMR dealing
1st May 20247:00 amRNSTransaction in Own Shares & Total Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20249:12 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTreasury shares issued
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTreasury shares issued & PDMR dealing
8th Apr 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSAudited results for year ended 31 December 2023
19th Mar 20247:00 amRNSNotice of Preliminary Results
26th Jan 20247:00 amRNSRule 19.6(c) confirmation of post-offer intentions
22nd Dec 20237:00 amRNSRule 19.6(b) update to post-offer intentions
18th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 202312:00 pmRNSTransaction in Own Shares
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
23rd Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTrading Update
13th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20237:00 amRNSTransaction in Own Shares
9th Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSTransaction in Own Shares
6th Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 20237:00 amRNSTotal Voting Rights
30th Oct 20237:00 amRNSTransaction in Own Shares
27th Oct 20233:57 pmRNSTreasury Stock
27th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 20237:00 amRNSTransaction in own shares
25th Oct 20237:00 amRNSTransaction in Own Shares
24th Oct 20237:00 amRNSTransaction in Own Shares
23rd Oct 20237:00 amRNSTransaction in Own Shares
20th Oct 20237:00 amRNSTransaction in Own Shares
16th Oct 20237:01 amRNSTransaction in Own Shares
16th Oct 20237:00 amRNSTreasury & EBT Shares Issued
13th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20237:00 amRNSTransaction in Own Shares
5th Oct 20237:00 amRNSTransaction in Own Shares
4th Oct 20237:00 amRNSTransaction in Own Shares
2nd Oct 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.